医薬品製造市場の規模、シェア、動向分析レポート：投与経路別、分子タイプ別、医薬品開発タイプ別、販売チャネル別、年齢層別、剤形別、地域別、セグメント別予測、2023年～2030年

医薬品製造市場の成長と動向

Grand View Research社の最新レポートによると、世界の医薬品製造市場規模は2030年までに9,299億米ドルに達すると予測されています。

2023年から2030年までのCAGRは7.63%で成長する見込みです。製薬業界は、技術の進歩、費用対効果の高い方法、投資の増加の結果、大きな変貌を遂げてきました。これらの要因は、市場の成長にプラスの影響を与えています。ロボット技術と人工知能（AI）の導入は、製造現場のダウンタイムを減らし、製品の無駄を最小限に抑える上で重要な役割を果たしています。これらの技術を取り入れることで、医薬品製造プロセスの効率と生産性が大幅に改善されました。

加えて、従来のオープン・トランスファー製法は、シングルユースの使い捨てソリューションの採用によって置き換えられ、業務の合理化と汚染リスクの低減につながっています。さらに、業界内では、統合されたスマートでデータ豊富なペーパーレス業務への移行が顕著になっています。この移行により、エラーのない正確な生産プロセスが実現し、高品質の医薬品が生産されるようになっています。市場におけるこうした継続的な進歩は、医薬品製造の進歩に大きく貢献しています。個別化医療の発展はヘルスケア分野に革命をもたらし、さまざまな健康状態を対象とする新たな機会を提供し、患者中心のモデルへの道を開いた。

その結果、複雑な医薬品や個々の患者に合わせた個別化治療の開発に対応するため、大量生産から少量生産へのシフトが進んでいます。この変革的なシフトにより、メーカーは患者中心のヘルスケアシステムに沿ったサプライチェーンの再構築を迫られています。こうしたすべての要因が、予測期間における医薬品製造市場の成長を後押ししています。さらに、製薬業界の大手企業は、市場での存在感を高め、競争上の優位性を獲得するために戦略的イニシアチブをとっています。これらの主な企業は、製品開発、提携・パートナーシップモデル、契約、事業拡大、M&A戦略など、さまざまな活動に積極的に取り組んでいます。

これらのイニシアチブは、製品ポートフォリオを強化し、医薬品需要の増大に対応することも目的としています。例えば、フェリング・ファーマシューティカルズは2022年4月、インドのハイデラバードに統合製造・研究開発（R&D）施設を開設しました。この施設は、事業と能力の拡大に対するフェリングのコミットメントを強調するものです。この施設の研究開発部門は、包装開発、製剤開発、分析開発などの分野に重点を置いています。フェリング・ファーマシューティカルズは、これらの分野に投資することで、製品の提供を強化し、市場の進化するニーズに応えることを目指しています。

医薬品製造市場レポートハイライト

• 2022年には、従来型医薬品（低分子）分野が54.9%超の最高売上高シェアを占めました。これは、低分子製品が容易に入手可能であり、市場浸透率が高いことに起因します。
• 2022年の市場シェアは、アウトソーシング部門が53%超を占めました。アウトソーシング業務に関連するいくつかの利点が、今後数年間、同分野の成長を有利なペースで促進すると予想されます。
• 収益面では、タブレット端末分野が2022年に26.08%超のシェアで市場を独占しました。これは、フィルム錠や腸溶錠、発泡錠、口腔内崩壊錠など、錠剤ベースの製品やタイプが幅広く入手可能なためです。
• 経口剤セグメントは2022年に58％以上のシェアで世界市場をリードしました。経口剤形は手頃な価格で製造が容易であり、患者に優しいです。
• 処方薬セグメントは、2022年に83.76%の最大収益シェアを占め、世界中で処方薬支出が増加しているため、予測期間中に安定したCAGRでさらに拡大します。
• 北米が市場を独占し、2022年に大きな収益シェアを占めたのは、この地域で特に老舗企業や創業間もない企業の間で戦略的製薬提携が数多く行われているためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医薬品製造市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 普及と成長の見通しマッピング
• 市場力学
  • 市場促進要因の分析
  • 市場抑制要因分析
• 医薬品製造市場分析ツール
  • 業界分析- ポーター
  • PESTEL分析

第4章 医薬品製造：分子タイプの推定・動向分析

• 定義と範囲
• 市場シェア、2022年・2030年
• セグメントダッシュボード
• 世界市場の見通し
• 市場規模、予測および動向分析、2018年～2030年
  • 生物製剤およびバイオシミラー（高分子）
  • 従来の薬剤（低分子）

第5章 医薬品製造：医薬品開発タイプの推定・動向分析

• 定義と範囲
• 市場シェア、2022年・2030年
• セグメントダッシュボード
• 世界市場の見通し
• 市場規模、予測および動向分析、2018年～2030年
  • 社内
  • アウトソーシング

第6章 医薬品製造：剤形の推定・動向分析

• 定義と範囲
• 市場シェア、2022年・2030年
• セグメントダッシュボード
• 世界市場の見通し
• 市場規模、予測および動向分析、2018年～2030年
  • 錠剤
  • カプセル
  • 注射
  • スプレー
  • サスペンション
  • 粉末
  • その他

第7章 医薬品製造：投与経路の推定・動向分析

• 定義と範囲
• 市場シェア、2022年・2030年
• セグメントダッシュボード
• 世界市場の見通し
• 市場規模、予測および動向分析、2018年～2030年
  • 経口
  • 外用
  • 非経口
  • 吸入
  • その他

第8章 医薬品製造：治療領域の推定・動向分析

• 定義と範囲
• 市場シェア、2022年・2030年
• セグメントダッシュボード
• 世界市場の見通し
• 市場規模、予測および動向分析、2018年～2030年
  • 心血管疾患
  • 疼痛
  • 糖尿病
  • がん
  • 呼吸器疾患
  • その他

第9章 医薬品製造：処方箋の推定・動向分析

• 定義と範囲
• 市場シェア、2022年・2030年
• セグメントダッシュボード
• 世界市場の見通し
• 市場規模、予測および動向分析、2018年～2030年
  • 処方薬
  • 市販薬（OTC）

第10章 医薬品製造：年齢層の推定・動向分析

• 定義と範囲
• 市場シェア、2022年・2030年
• セグメントダッシュボード
• 世界市場の見通し
• 市場規模、予測および動向分析、2018年～2030年
  • 子供と青少年
  • 大人
  • 高齢者向け

第11章 医薬品製造：販売チャネルの推定・動向分析

• 定義と範囲
• 市場シェア、2022年・2030年
• セグメントダッシュボード
• 世界市場の見通し
• 市場規模、予測および動向分析、2018年～2030年
  • 小売り
  • 非小売

第12章 医薬品製造市場：地域推定・動向分析

• 地域市場シェア分析、2022年および2030年
• 地域市場ダッシュボード
• 世界の地域市場のスナップショット
• 地域市場シェアと主要企業、2021年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• SWOT分析、要因別（政治・法律、経済・技術）
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• 市場規模、予測、数量および動向分析、2018年から2030年：
• 北米
  • SWOT分析
  • 北米市場推計・予測、2018年から2030年
  • 米国
  • カナダ
• 欧州
  • SWOT分析
  • 欧州市場推計・予測、2018年から2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • SWOT分析
  • アジア太平洋市場推計・予測、2018年から2030年
  • 中国
  • 日本
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • SWOT分析
  • ラテンアメリカ市場推計・予測、2018～2030年
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • SWOT分析
  • MEA市場推計・予測、2018年から2030年
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • クウェート

第13章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 会社/競合の分類
  • イノベーター
• ベンダー情勢
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • GlaxoSmithKline plc
  • Pfizer, Inc.
  • Merck &Co., Inc.
  • AstraZeneca
  • Johnson &Johnson Services, Inc.
  • Sanofi SA
  • Eli Lilly and Company
  • AbbVie, Inc.
  • Thermo Fisher Scientific, Inc.
  • Wuxi Apptec
  • Samsung Biologics
  • FUJIFILM Diosynth Biotechnologies USA, Inc.
  • Lonza
  • Catalent Pharma Solutions
  • Jubilant Pharmova Limited

List of Tables

• Table 1 List of Abbreviation
• Table 2 Global pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 3 Global pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 4 Global pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 5 Global pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 6 Global pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 7 Global pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 8 Global pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 9 Global pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 10 Global pharmaceutical manufacturing market, by region, 2018 - 2030 (USD Billion)
• Table 11 North America pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 12 North America pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 13 North America pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 14 North America pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 15 North America pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 16 North America pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 17 North America pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 18 North America pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 19 U.S. pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 20 U.S. pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 21 U.S. pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 22 U.S. pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 23 U.S. pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 24 U.S. pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 25 U.S. pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 26 U.S. pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 27 Canada pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 28 Canada pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 29 Canada pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 30 Canada pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 31 Canada pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 32 Canada pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 33 Canada pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 34 Canada pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 35 Europe pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 36 Europe pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 37 Europe pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 38 Europe pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 39 Europe pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 40 Europe pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 41 Europe pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 42 Europe pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 43 Germany pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 44 Germany pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 45 Germany pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 46 Germany pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 47 Germany pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 48 Germany pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 49 Germany pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 50 Germany pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 51 UK pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 52 UK pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 53 UK pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 54 UK pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 55 UK pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 56 UK pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 57 UK pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 58 UK pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 59 France pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 60 France pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 61 France pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 62 France pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 63 France pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 64 France pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 65 France pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 66 France pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 67 Italy pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 68 Italy pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 69 Italy pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 70 Italy pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 71 Italy pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 72 Italy pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 73 Italy pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 74 Italy pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 75 Spain pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 76 Spain pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 77 Spain pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 78 Spain pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 79 Spain pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 80 Spain pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 81 Spain pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 82 Spain pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 83 Sweden pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 84 Sweden pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 85 Sweden pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 86 Sweden pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 87 Sweden pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 88 Sweden pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 89 Sweden pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 90 Sweden pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 91 Norway pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 92 Norway pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 93 Norway pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 94 Norway pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 95 Norway pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 96 Norway pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 97 Norway pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 98 Norway pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 99 Denmark pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 100 Denmark pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 101 Denmark pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 102 Denmark pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 103 Denmark pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 104 Denmark pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 105 Denmark pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 106 Denmark pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 107 Asia Pacific pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 108 Asia Pacific pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 109 Asia Pacific pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 110 Asia Pacific pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 111 Asia Pacific pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 112 Asia Pacific pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 113 Asia Pacific pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 114 Asia Pacific pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 115 China pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 116 China pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 117 China pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 118 China pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 119 China pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 120 China pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 121 China pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 122 China pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 123 Japan pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 124 Japan pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 125 Japan pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 126 Japan pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 127 Japan pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 128 Japan pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 129 Japan pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 130 Japan pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 131 India pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 132 India pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 133 India pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 134 India pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 135 India pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 136 India pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 137 India pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 138 India pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 139 Thailand pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 140 Thailand pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 141 Thailand pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 142 Thailand pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 143 Thailand pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 144 Thailand pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 145 Thailand pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 146 Thailand pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 147 South Korea pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 148 South Korea pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 149 South Korea pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 150 South Korea pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 151 South Korea pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 152 South Korea pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 153 South Korea pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 154 South Korea pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 155 Australia pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 156 Australia pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 157 Australia pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 158 Australia pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 159 Australia pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 160 Australia pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 161 Australia pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 162 Australia pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 163 Latin America pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 164 Latin America pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 165 Latin America pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 166 Latin America pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 167 Latin America pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 168 Latin America pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 169 Latin America pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 170 Latin America pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 171 Brazil pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 172 Brazil pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 173 Brazil pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 174 Brazil pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 175 Brazil pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 176 Brazil pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 177 Brazil pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 178 Brazil pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 179 Mexico pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 180 Mexico pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 181 Mexico pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 182 Mexico pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 183 Mexico pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 184 Mexico pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 185 Mexico pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 186 Mexico pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 187 Argentina pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 188 Argentina pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 189 Argentina pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 190 Argentina pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 191 Argentina pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 192 Argentina pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 193 Argentina pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 194 Argentina pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 195 Middle East and Africa pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 196 Middle East and Africa pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 197 Middle East and Africa pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 198 Middle East and Africa pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 199 Middle East and Africa pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 200 Middle East and Africa pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 201 Middle East and Africa pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 202 Middle East and Africa pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 203 South Africa pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 204 South Africa pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 205 South Africa pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 206 South Africa pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 207 South Africa pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 208 South Africa pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 209 South Africa pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 210 South Africa pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 211 Saudi Arabia pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 212 Saudi Arabia pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 213 Saudi Arabia pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 214 Saudi Arabia pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 215 Saudi Arabia pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 216 Saudi Arabia pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 217 Saudi Arabia pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 218 Saudi Arabia pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 219 UAE pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 220 UAE pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 221 UAE pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 222 UAE pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 223 UAE pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 224 UAE pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 225 UAE pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 226 UAE pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)
• Table 227 Kuwait pharmaceutical manufacturing market, by molecule type, 2018 - 2030 (USD Billion)
• Table 228 Kuwait pharmaceutical manufacturing market, by drug development type, 2018 - 2030 (USD Billion)
• Table 229 Kuwait pharmaceutical manufacturing market, by formulation, 2018 - 2030 (USD Billion)
• Table 230 Kuwait pharmaceutical manufacturing market, by route of administration, 2018 - 2030 (USD Billion)
• Table 231 Kuwait pharmaceutical manufacturing market, by therapy area, 2018 - 2030 (USD Billion)
• Table 232 Kuwait pharmaceutical manufacturing market, by prescription, 2018 - 2030 (USD Billion)
• Table 233 Kuwait pharmaceutical manufacturing market, by age group, 2018 - 2030 (USD Billion)
• Table 234 Kuwait pharmaceutical manufacturing market, by sales channel, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Pharmaceutical manufacturing: market outlook
• Fig. 9 Pharmaceutical manufacturing competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 Pharmaceutical manufacturing market driver impact
• Fig. 15 Pharmaceutical manufacturing market restraint impact
• Fig. 16 Pharmaceutical manufacturing market strategic initiatives analysis
• Fig. 17 Pharmaceutical manufacturing market: molecule type movement analysis
• Fig. 18 Pharmaceutical manufacturing market: molecule type outlook and key takeaways
• Fig. 19 Large molecules market estimates and forecast, 2018 - 2030
• Fig. 20 Monoclonal Antibodies market estimates and forecast, 2018 - 2030
• Fig. 21 Vaccines market estimates and forecast, 2018 - 2030
• Fig. 22 Cell & Gene Therapy market estimates and forecast, 2018 - 2030
• Fig. 23 Others market estimates and forecast, 2018 - 2030
• Fig. 24 Small molecules market estimates and forecast, 2018 - 2030
• Fig. 25 Pharmaceutical manufacturing market: drug development type movement analysis
• Fig. 26 Pharmaceutical manufacturing market: drug development type outlook and key takeaways
• Fig. 27 Outsource market estimates and forecast, 2018 - 2030
• Fig. 28 In-house market estimates and forecast, 2018 - 2030
• Fig. 29 Pharmaceutical manufacturing market: formulation movement analysis
• Fig. 30 Pharmaceutical manufacturing market: formulation outlook and key takeaways
• Fig. 31 Tablets market estimates and forecast, 2018 - 2030
• Fig. 32 Capsules market estimates and forecast, 2018 - 2030
• Fig. 33 Injectable market estimates and forecast, 2018 - 2030
• Fig. 34 Sprays market estimates and forecast, 2018 - 2030
• Fig. 35 Suspensions market estimates and forecast, 2018 - 2030
• Fig. 36 Powders market estimates and forecast, 2018 - 2030
• Fig. 37 Others market estimates and forecast, 2018 - 2030
• Fig. 38 Pharmaceutical manufacturing market: route of administration movement analysis
• Fig. 39 Pharmaceutical manufacturing market: route of administration outlook and key takeaways
• Fig. 40 Oral market estimates and forecast, 2018 - 2030
• Fig. 41 Topical market estimates and forecast, 2018 - 2030
• Fig. 42 Parenteral market estimates and forecast, 2018 - 2030
• Fig. 43 Inhalation market estimates and forecast, 2018 - 2030
• Fig. 44 Others market estimates and forecast, 2018 - 2030
• Fig. 45 Pharmaceutical manufacturing market: Therapy area movement analysis
• Fig. 46 Pharmaceutical manufacturing market: Therapy Area outlook and key takeaways
• Fig. 47 CVDs market estimates and forecast, 2018 - 2030
• Fig. 48 Pain market estimates and forecast, 2018 - 2030
• Fig. 49 Diabetes management market estimates and forecast, 2018 - 2030
• Fig. 50 Cancer market estimates and forecast, 2018 - 2030
• Fig. 51 Respiratory diseases market estimates and forecast, 2018 - 2030
• Fig. 52 Others market estimates and forecast, 2018 - 2030
• Fig. 53 Pharmaceutical manufacturing market: prescription movement analysis
• Fig. 54 Pharmaceutical manufacturing market: prescription outlook and key takeaways
• Fig. 55 Prescription medicines market estimates and forecast, 2018 - 2030
• Fig. 56 Over-the-counter medicines market estimates and forecast, 2018 - 2030
• Fig. 57 Pharmaceutical manufacturing market: age-group movement analysis
• Fig. 58 Pharmaceutical manufacturing market: age-group outlook and key takeaways
• Fig. 59 Children & Adolescents market estimates and forecast, 2018 - 2030
• Fig. 60 Adults market estimates and forecast, 2018 - 2030
• Fig. 61 Geriatric market estimates and forecast, 2018 - 2030
• Fig. 62 Pharmaceutical manufacturing market: sales channel movement analysis
• Fig. 63 Pharmaceutical manufacturing market: sales channel outlook and key takeaways
• Fig. 64 Retail market estimates and forecast, 2018 - 2030
• Fig. 65 Non-Retail market estimates and forecast, 2018 - 2030
• Fig. 66 Global Pharmaceutical manufacturing market: regional movement analysis
• Fig. 67 Global Pharmaceutical manufacturing market: regional outlook and key takeaways
• Fig. 68 Global market share and leading players
• Fig. 69 North America market share and leading players
• Fig. 70 Europe market share and leading players
• Fig. 71 Asia Pacific market share and leading players
• Fig. 72 Latin America market share and leading players
• Fig. 73 Middle East & Africa market share and leading players
• Fig. 74 North America: SWOT
• Fig. 75 Europe SWOT
• Fig. 76 Asia Pacific SWOT
• Fig. 77 Latin America SWOT
• Fig. 78 MEA SWOT
• Fig. 79 North America, by country
• Fig. 80 North America
• Fig. 81 North America market estimates and forecast, 2018 - 2030
• Fig. 82 U.S. Key Country Dynamics
• Fig. 83 U.S. market estimates and forecast, 2018 - 2030
• Fig. 84 Canada Key Country Dynamics
• Fig. 85 Canada market estimates and forecast, 2018 - 2030
• Fig. 86 Europe
• Fig. 87 Europe. market estimates and forecast, 2018 - 2030
• Fig. 88 UK Key Country Dynamics
• Fig. 89 UK market estimates and forecast, 2018 - 2030
• Fig. 90 Germany Key Country Dynamics
• Fig. 91 Germany market estimates and forecast, 2018 - 2030
• Fig. 92 France Key Country Dynamics
• Fig. 93 France market estimates and forecast, 2018 - 2030
• Fig. 94 Italy Key Country Dynamics
• Fig. 95 Italy market estimates and forecast, 2018 - 2030
• Fig. 96 Spain Key Country Dynamics
• Fig. 97 Spain market estimates and forecast, 2018 - 2030
• Fig. 98 Sweden Key Country Dynamics
• Fig. 99 Sweden market estimates and forecast, 2018 - 2030
• Fig. 100 Norway Key Country Dynamics
• Fig. 101 Norway market estimates and forecast, 2018 - 2030
• Fig. 102 Denmark Key Country Dynamics
• Fig. 103 Denmark market estimates and forecast, 2018 - 2030
• Fig. 104 Asia Pacific Key Country Dynamics
• Fig. 105 Asia Pacific market estimates and forecast, 2018 - 2030
• Fig. 106 China Key Country Dynamics
• Fig. 107 China market estimates and forecast, 2018 - 2030
• Fig. 108 Japan Key Country Dynamics
• Fig. 109 Japan market estimates and forecast, 2018 - 2030
• Fig. 110 India Key Country Dynamics
• Fig. 111 India market estimates and forecast, 2018 - 2030
• Fig. 112 Australia Key Country Dynamics
• Fig. 113 Australia market estimates and forecast, 2018 - 2030
• Fig. 114 Thailand Key Country Dynamics
• Fig. 115 Thailand market estimates and forecast, 2018 - 2030
• Fig. 116 South Korea Key Country Dynamics
• Fig. 117 South Korea market estimates and forecast, 2018 - 2030
• Fig. 118 Latin America
• Fig. 119 Latin America market estimates and forecast, 2018 - 2030
• Fig. 120 Brazil Key Country Dynamics
• Fig. 121 Brazil market estimates and forecast, 2018 - 2030
• Fig. 122 Mexico Key Country Dynamics
• Fig. 123 Mexico market estimates and forecast, 2018 - 2030
• Fig. 124 Argentina Key Country Dynamics
• Fig. 125 Argentina market estimates and forecast, 2018 - 2030
• Fig. 126 Middle East and Africa
• Fig. 127 Middle East and Africa. market estimates and forecast, 2018 - 2030
• Fig. 128 Saudi Arabia Key Country Dynamics
• Fig. 129 Saudi Arabia market estimates and forecast, 2018 - 2030
• Fig. 130 South Africa Key Country Dynamics
• Fig. 131 South Africa market estimates and forecast, 2018 - 2030
• Fig. 132 UAE Key Country Dynamics
• Fig. 133 UAE market estimates and forecast, 2018 - 2030
• Fig. 134 Kuwait Key Country Dynamics
• Fig. 135 Kuwait market estimates and forecast, 2018 - 2030
• Fig. 136 Participant categorization - Pharmaceutical manufacturing market
• Fig. 137 Market share of key market players - Pharmaceutical manufacturing market

Pharmaceutical Manufacturing Market Growth & Trends

The global pharmaceutical manufacturing market size is expected to reach USD 929.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 7.63% from 2023 to 2030. The pharmaceutical industry has undergone significant transformations as a result of technological advancements, cost-effective methods, and increased investments. These factors have had a positive impact on the growth of the market. The implementation of robotic technology and Artificial Intelligence (AI) has played a crucial role in reducing manufacturing floor downtime and minimizing product waste. By incorporating these technologies, efficiency, and productivity in pharmaceutical manufacturing processes have been greatly improved.

In addition, traditional open-transfer manufacturing methods have been replaced by the adoption of single-use disposable solutions, leading to streamlined operations and reduced risks of contamination. Moreover, there has been a notable shift toward integrated, smart, and data-rich paperless operations within the industry. This transition has resulted in error-free and precise production processes, ensuring the production of high-quality pharmaceutical products. These ongoing advancements in the market have significantly contributed to the progress of drug manufacturing. The development of personalized medicine has brought about a revolution in the healthcare sector, offering new opportunities to target various health conditions and paving the way for patient-centric models.

Consequently, there has been a shift from large-scale production to smaller batches to cater to the development of complex medicines and personalized treatments tailored to individual patients. This transformative shift has prompted manufacturers to restructure their supply chains in alignment with the patient-centric healthcare system. All such factors propel pharmaceutical manufacturing market growth over the forecast period. Furthermore, leading companies in the pharmaceutical industry have taken strategic initiatives to enhance their market presence and gain a competitive advantage. These key players actively engage in various activities, such as product development, collaboration & partnership models, agreements, business expansion, and merger & acquisition strategies.

These initiatives are also aimed at strengthening their product portfolios and meeting the growing demand for pharmaceutical products. For instance, in April 2022, Ferring Pharmaceuticals inaugurated an integrated manufacturing and research and development (R&D) facility in Hyderabad, India. This facility underscores Ferring's commitment to expanding its operations and capabilities. The R&D division of the facility focuses on areas, such as packaging development, formulation development, and analytical development. Ferring Pharmaceuticals aims to enhance its product offerings and meet the evolving needs of the market by investing in these areas.

Pharmaceutical Manufacturing Market Report Highlights

• In 2022, the conventional drugs (small molecules) segment accounted for the highest revenue share of over 54.9%. This is attributed to the easy availability of small molecules products, with high market penetration
• The outsourcing segment dominated the market in 2022 with a revenue share of over 53%. Several benefits associated with outsourcing operations are expected to drive the segment growth at a lucrative pace over the coming years
• In terms of revenue, the tablets segment dominated the market with a share of over 26.08 % in 2022. This is due to the wide availability of tablet-based products and types, such as film and enteric-coated, effervescent, and orally disintegrating tablets
• The oral segment led the global market with a share of more than 58% in 2022. Oral dosage forms are affordable, easy to manufacture, and patient-friendly
• The prescription medicines segment accounted for the maximum revenue share of 83.76% in 2022 and will expand further at a steady CAGR over the forecast period due to the growing prescription drug expenditures across the globe
• North America dominated the market and accounted for a significant revenue share in 2022 due to a large number of strategic pharma partnerships, especially among the well-established and early-stage companies, in this region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Molecule Type
  • 1.2.2. Drug Development Type
  • 1.2.3. Formulation
  • 1.2.4. Routes of Administration
  • 1.2.5. Therapy Area
  • 1.2.6. Prescription
  • 1.2.7. Age Group
  • 1.2.8. Sales Channel
• 1.3. Regional Scope
• 1.4. Estimates and Forecast Timeline
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased database
  • 1.6.2. GVR's internal database
  • 1.6.3. Secondary sources
  • 1.6.4. Primary research
  • 1.6.5. Details of primary research
• 1.7. Information or Data Analysis
  • 1.7.1. Data analysis models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1.1. Commodity flow analysis (Model 1)
  • 1.9.1.2. Approach 1: Commodity flow approach
  • 1.9.1.3. Volume price analysis (Model 2)
  • 1.9.1.4. Approach 2: Volume price analysis
• 1.10. List of Secondary Sources
• 1.11. List of Primary Sources
• 1.12. Objectives
  • 1.12.1. Objective 1
  • 1.12.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Molecule Type outlook
  • 2.2.2. Drug Development Type outlook
  • 2.2.3. Formulation outlook
  • 2.2.4. Route of Administration outlook
  • 2.2.5. Therapy Area outlook
  • 2.2.6. Prescription outlook
  • 2.2.7. Age Group outlook
  • 2.2.8. Sales Channel outlook
  • 2.2.9. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Pharmaceutical Manufacturing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Rise in pharmaceutical R&D spending
    • 3.3.1.2. Rise in focus toward healthcare needs in emerging nations
    • 3.3.1.3. Technological advancements
    • 3.3.1.4. Increase in geriatric population and incidence of chronic disorders
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. Patent expiration of most profitable drugs
    • 3.3.2.2. Pricing pressures on bio/pharmaceutical companies
• 3.4. Pharmaceutical manufacturing Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. Pharmaceutical Manufacturing: Molecule Type Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Biologics & Biosimilars (Large Molecules)
  • 4.1.2. Conventional Drugs (Small Molecules)
• 4.2. Molecule Type Market Share, 2022 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Pharmaceutical Manufacturing Market by Molecule Type Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Biologics & Biosimilars (Large Molecules)
    • 4.5.1.1. Biologics & Biosimilars (Large Molecules) market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.1.2. Monoclonal Antibodies
    • 4.5.1.2.1. Monoclonal Antibodies market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.1.3. Vaccines
    • 4.5.1.3.1. Vaccines market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.1.4. Cell & Gene Therapy
    • 4.5.1.4.1. Cell & Gene Therapy market estimates and forecast 2018 to 2030 (USD Billion)
    • 4.5.1.5. Others
    • 4.5.1.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)
  • 4.5.2. Conventional Drugs (Small Molecules)
    • 4.5.2.1. Conventional Drugs (Small Molecules) market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 5. Pharmaceutical Manufacturing: Drug Development Type Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. In-house
  • 5.1.2. Outsource
• 5.2. Drug Development Type Market Share, 2022 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Microneedle Drug Delivery Systems Market by Drug Development Type Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
  • 5.5.1. In-house
    • 5.5.1.1. In-house market estimates and forecast 2018 to 2030 (USD Billion)
  • 5.5.2. Outsource
    • 5.5.2.1. Outsource market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 6. Pharmaceutical Manufacturing: Formulation Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Tablets
  • 6.1.2. Capsules
  • 6.1.3. Injectable
  • 6.1.4. Sprays
  • 6.1.5. Suspensions
  • 6.1.6. Powders
  • 6.1.7. Others
• 6.2. Formulation Market Share, 2022 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Pharmaceutical Manufacturing Market by Formulation Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Tablets
    • 6.5.1.1. Tablets market estimates and forecast 2018 to 2030 (USD Billion)
  • 6.5.2. Capsules
    • 6.5.2.1. Capsules market estimates and forecast 2018 to 2030 (USD Billion)
  • 6.5.3. Injectable
    • 6.5.3.1. Injectable market estimates and forecast 2018 to 2030 (USD Billion)
  • 6.5.4. Sprays
    • 6.5.4.1. Sprays market estimates and forecast 2018 to 2030 (USD Billion)
  • 6.5.5. Suspensions
    • 6.5.5.1. Suspensions market estimates and forecast 2018 to 2030 (USD Billion)
  • 6.5.6. Powders
    • 6.5.6.1. Powders market estimates and forecast 2018 to 2030 (USD Billion)
  • 6.5.7. Others
    • 6.5.7.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 7. Pharmaceutical Manufacturing: Route of Administration Estimates & Trend Analysis

• 7.1. Definitions and Scope
  • 7.1.1. Oral
  • 7.1.2. Topical
  • 7.1.3. Parenteral
  • 7.1.4. Inhalations
  • 7.1.5. Others
• 7.2. Route of Administration Market Share, 2022 & 2030
• 7.3. Segment Dashboard
• 7.4. Global Pharmaceutical Manufacturing Market by Route of Administration Outlook
• 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5.1. Oral
    • 7.5.1.1. Oral market estimates and forecast 2018 to 2030 (USD Billion)
  • 7.5.2. Topical
    • 7.5.2.1. Topical market estimates and forecast 2018 to 2030 (USD Billion)
  • 7.5.3. Parenteral
    • 7.5.3.1. Parenteral market estimates and forecast 2018 to 2030 (USD Billion)
  • 7.5.4. Inhalations
    • 7.5.4.1. Inhalations market estimates and forecast 2018 to 2030 (USD Billion)
  • 7.5.5. Others
    • 7.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 8. Pharmaceutical Manufacturing: Therapy Area Estimates & Trend Analysis

• 8.1. Definitions and Scope
  • 8.1.1. Cardiovascular diseases
  • 8.1.2. Pain
  • 8.1.3. Diabetes
  • 8.1.4. Cancer
  • 8.1.5. Respiratory diseases
  • 8.1.6. Others
• 8.2. Therapy Area Market Share, 2022 & 2030
• 8.3. Segment Dashboard
• 8.4. Global Pharmaceutical Manufacturing Market by Therapy Area Outlook
• 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5.1. Cardiovascular diseases
    • 8.5.1.1. Cardiovascular diseases market estimates and forecast 2018 to 2030 (USD Billion)
  • 8.5.2. Pain
    • 8.5.2.1. Pain market estimates and forecast 2018 to 2030 (USD Billion)
  • 8.5.3. Diabetes
    • 8.5.3.1. Diabetes market estimates and forecast 2018 to 2030 (USD Billion)
  • 8.5.4. Cancer
    • 8.5.4.1. Cancer market estimates and forecast 2018 to 2030 (USD Billion)
  • 8.5.5. Respiratory diseases
    • 8.5.5.1. Respiratory diseases market estimates and forecast 2018 to 2030 (USD Billion)
  • 8.5.6. Others
    • 8.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 9. Pharmaceutical Manufacturing: Prescription Estimates & Trend Analysis

• 9.1. Definitions and Scope
  • 9.1.1. Prescription Medicines
  • 9.1.2. Over-the-counter (OTC) medicines
• 9.2. Prescription Market Share, 2022 & 2030
• 9.3. Segment Dashboard
• 9.4. Global Pharmaceutical Manufacturing Market by Prescription Outlook
• 9.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 9.5.1. Prescription Medicines
    • 9.5.1.1. Prescription Medicines market estimates and forecast 2018 to 2030 (USD Billion)
  • 9.5.2. Over-the-counter (OTC) medicines
    • 9.5.2.1. Over-the-counter (OTC) medicines market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 10. Pharmaceutical Manufacturing: Age Group Estimates & Trend Analysis

• 10.1. Definitions and Scope
  • 10.1.1. Children & Adolescents
  • 10.1.2. Adults
  • 10.1.3. Geriatric
• 10.2. Age Group Market Share, 2022 & 2030
• 10.3. Segment Dashboard
• 10.4. Global Pharmaceutical Manufacturing Market by Age Group Outlook
• 10.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030for the following
  • 10.5.1. Children & Adolescents
    • 10.5.1.1. Children & Adolescents market estimates and forecast 2018 to 2030 (USD Billion)
  • 10.5.2. Adults
    • 10.5.2.1. Adults market estimates and forecast 2018 to 2030 (USD Billion)
  • 10.5.3. Geriatric
    • 10.5.3.1. Geriatric market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 11. Pharmaceutical Manufacturing: Sales Channel Estimates & Trend Analysis

• 11.1. Definitions and Scope
  • 11.1.1. Retail
  • 11.1.2. Non-retail
• 11.2. Sales Channel Market Share, 2022 & 2030
• 11.3. Segment Dashboard
• 11.4. Global Pharmaceutical Manufacturing Market by Sales Channel Outlook
• 11.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 11.5.1. Retail
    • 11.5.1.1. Retail market estimates and forecast 2018 to 2030 (USD Billion)
  • 11.5.2. Non-retail
    • 11.5.2.1. Non-retail market estimates and forecast 2018 to 2030 (USD Billion)

Chapter 12. Pharmaceutical Manufacturing Market: Regional Estimates & Trend Analysis

• 12.1. Regional market share analysis, 2022 & 2030
• 12.2. Regional Market Dashboard
• 12.3. Global Regional Market Snapshot
• 12.4. Regional Market Share and Leading Players, 2021
  • 12.4.1. North America
  • 12.4.2. Europe
  • 12.4.3. Asia Pacific
  • 12.4.4. Latin America
  • 12.4.5. Middle East and Africa
• 12.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
  • 12.5.1. North America
  • 12.5.2. Europe
  • 12.5.3. Asia Pacific
  • 12.5.4. Latin America
  • 12.5.5. Middle East and Africa
• 12.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
• 12.7. North America
  • 12.7.1. SWOT Analysis
  • 12.7.2. North America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.7.3. U.S.
    • 12.7.3.1. Key Country Dynamics
    • 12.7.3.2. Target Disease Prevalence
    • 12.7.3.3. Competitive Scenario
    • 12.7.3.4. Regulatory Framework
    • 12.7.3.5. U.S. Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.7.4. Canada
    • 12.7.4.1. Key Country Dynamics
    • 12.7.4.2. Target Disease Prevalence
    • 12.7.4.3. Competitive Scenario
    • 12.7.4.4. Regulatory Framework
    • 12.7.4.5. Canada Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
• 12.8. Europe
  • 12.8.1. SWOT Analysis
  • 12.8.2. Europe Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.8.3. UK
    • 12.8.3.1. Key Country Dynamics
    • 12.8.3.2. Target Disease Prevalence
    • 12.8.3.3. Competitive Scenario
    • 12.8.3.4. Regulatory Framework
    • 12.8.3.5. UK Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.8.4. Germany
    • 12.8.4.1. Key Country Dynamics
    • 12.8.4.2. Target Disease Prevalence
    • 12.8.4.3. Competitive Scenario
    • 12.8.4.4. Regulatory Framework
    • 12.8.4.5. Germany Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.8.5. France
    • 12.8.5.1. Key Country Dynamics
    • 12.8.5.2. Target Disease Prevalence
    • 12.8.5.3. Competitive Scenario
    • 12.8.5.4. Regulatory Framework
    • 12.8.5.5. France Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.8.6. Italy
    • 12.8.6.1. Key Country Dynamics
    • 12.8.6.2. Target Disease Prevalence
    • 12.8.6.3. Competitive Scenario
    • 12.8.6.4. Regulatory Framework
    • 12.8.6.5. Italy Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.8.7. Spain
    • 12.8.7.1. Key Country Dynamics
    • 12.8.7.2. Target Disease Prevalence
    • 12.8.7.3. Competitive Scenario
    • 12.8.7.4. Regulatory Framework
    • 12.8.7.5. Spain Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.8.8. Denmark
    • 12.8.8.1. Key Country Dynamics
    • 12.8.8.2. Target Disease Prevalence
    • 12.8.8.3. Competitive Scenario
    • 12.8.8.4. Regulatory Framework
    • 12.8.8.5. Denmark Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.8.9. Sweden
    • 12.8.9.1. Key Country Dynamics
    • 12.8.9.2. Target Disease Prevalence
    • 12.8.9.3. Competitive Scenario
    • 12.8.9.4. Regulatory Framework
    • 12.8.9.5. Sweden Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.8.10. Norway
    • 12.8.10.1. Key Country Dynamics
    • 12.8.10.2. Target Disease Prevalence
    • 12.8.10.3. Competitive Scenario
    • 12.8.10.4. Regulatory Framework
    • 12.8.10.5. Norway Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
• 12.9. Asia Pacific
  • 12.9.1. SWOT Analysis
  • 12.9.2. Asia Pacific Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.9.3. China
    • 12.9.3.1. Key Country Dynamics
    • 12.9.3.2. Target Disease Prevalence
    • 12.9.3.3. Competitive Scenario
    • 12.9.3.4. Regulatory Framework
    • 12.9.3.5. China Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.9.4. Japan
    • 12.9.4.1. Key Country Dynamics
    • 12.9.4.2. Target Disease Prevalence
    • 12.9.4.3. Competitive Scenario
    • 12.9.4.4. Regulatory Framework
    • 12.9.4.5. Japan Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
  • 12.9.5. India
    • 12.9.5.1. Key Country Dynamics
    • 12.9.5.2. Target Disease Prevalence
    • 12.9.5.3. Competitive Scenario
    • 12.9.5.4. Regulatory Framework
    • 12.9.5.5. India Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.9.6. Australia
    • 12.9.6.1. Key Country Dynamics
    • 12.9.6.2. Target Disease Prevalence
    • 12.9.6.3. Competitive Scenario
    • 12.9.6.4. Regulatory Framework
    • 12.9.6.5. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.9.7. Thailand
    • 12.9.7.1. Key Country Dynamics
    • 12.9.7.2. Target Disease Prevalence
    • 12.9.7.3. Competitive Scenario
    • 12.9.7.4. Regulatory Framework
    • 12.9.7.5. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.9.8. South Korea
    • 12.9.8.1. Key Country Dynamics
    • 12.9.8.2. Target Disease Prevalence
    • 12.9.8.3. Competitive Scenario
    • 12.9.8.4. Regulatory Framework
    • 12.9.8.5. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
• 12.10. Latin America
  • 12.10.1. SWOT Analysis
  • 12.10.2. Latin America Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.10.3. Brazil
    • 12.10.3.1. Key Country Dynamics
    • 12.10.3.2. Target Disease Prevalence
    • 12.10.3.3. Competitive Scenario
    • 12.10.3.4. Regulatory Framework
    • 12.10.3.5. Brazil Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.10.4. Mexico
    • 12.10.4.1. Key Country Dynamics
    • 12.10.4.2. Target Disease Prevalence
    • 12.10.4.3. Competitive Scenario
    • 12.10.4.4. Regulatory Framework
    • 12.10.4.5. Mexico Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.10.5. Argentina
    • 12.10.5.1. Key Country Dynamics
    • 12.10.5.2. Target Disease Prevalence
    • 12.10.5.3. Competitive Scenario
    • 12.10.5.4. Regulatory Framework
    • 12.10.5.5. Argentina Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
• 12.11. MEA
  • 12.11.1. SWOT Analysis
  • 12.11.2. MEA Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.11.3. Saudi Arabia
    • 12.11.3.1. Key Country Dynamics
    • 12.11.3.2. Target Disease Prevalence
    • 12.11.3.3. Competitive Scenario
    • 12.11.3.4. Regulatory Framework
    • 12.11.3.5. Saudi Arabia Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.11.4. South Africa
    • 12.11.4.1. Key Country Dynamics
    • 12.11.4.2. Target Disease Prevalence
    • 12.11.4.3. Competitive Scenario
    • 12.11.4.4. Regulatory Framework
    • 12.11.4.5. South Africa Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.11.5. UAE
    • 12.11.5.1. Key Country Dynamics
    • 12.11.5.2. Target Disease Prevalence
    • 12.11.5.3. Competitive Scenario
    • 12.11.5.4. Regulatory Framework
    • 12.11.5.5. UAE Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)
  • 12.11.6. Kuwait
    • 12.11.6.1. Key Country Dynamics
    • 12.11.6.2. Target Disease Prevalence
    • 12.11.6.3. Competitive Scenario
    • 12.11.6.4. Regulatory Framework
    • 12.11.6.5. Kuwait Market estimates and forecast, 2018 - 2030 (Revenue, USD Billion)

Chapter 13. Competitive Landscape

• 13.1. Recent Developments & Impact Analysis, By Key Market Participants
• 13.2. Company/Competition Categorization
  • 13.2.1. Innovators
• 13.3. Vendor Landscape
  • 13.3.1. List of key distributors and channel partners
  • 13.3.2. Key customers
  • 13.3.3. Key company market share analysis, 2022
  • 13.3.4. F. Hoffmann-La Roche Ltd.
    • 13.3.4.1. Company overview
    • 13.3.4.2. Financial performance
    • 13.3.4.3. Product benchmarking
    • 13.3.4.4. Strategic initiatives
  • 13.3.5. Novartis AG
    • 13.3.5.1. Company overview
    • 13.3.5.2. Financial performance
    • 13.3.5.3. Product benchmarking
    • 13.3.5.4. Strategic initiatives
  • 13.3.6. GlaxoSmithKline plc
    • 13.3.6.1. Company overview
    • 13.3.6.2. Financial performance
    • 13.3.6.3. Product benchmarking
    • 13.3.6.4. Strategic initiatives
  • 13.3.7. Pfizer, Inc.
    • 13.3.7.1. Company overview
    • 13.3.7.2. Financial performance
    • 13.3.7.3. Product benchmarking
    • 13.3.7.4. Strategic initiatives
  • 13.3.8. Merck & Co., Inc.
    • 13.3.8.1. Company overview
    • 13.3.8.2. Financial performance
    • 13.3.8.3. Product benchmarking
    • 13.3.8.4. Strategic initiatives
  • 13.3.9. AstraZeneca
    • 13.3.9.1. Company overview
    • 13.3.9.2. Financial performance
    • 13.3.9.3. Product benchmarking
    • 13.3.9.4. Strategic initiatives
  • 13.3.10. Johnson & Johnson Services, Inc.
    • 13.3.10.1. Company overview
    • 13.3.10.2. Financial performance
    • 13.3.10.3. Product benchmarking
    • 13.3.10.4. Strategic initiatives
  • 13.3.11. Sanofi SA
    • 13.3.11.1. Company overview
    • 13.3.11.2. Financial performance
    • 13.3.11.3. Product benchmarking
    • 13.3.11.4. Strategic initiatives
  • 13.3.12. Eli Lilly and Company
    • 13.3.12.1. Company overview
    • 13.3.12.2. Financial performance
    • 13.3.12.3. Product benchmarking
    • 13.3.12.4. Strategic initiatives
  • 13.3.13. AbbVie, Inc.
    • 13.3.13.1. Company overview
    • 13.3.13.2. Financial performance
    • 13.3.13.3. Product benchmarking
    • 13.3.13.4. Strategic initiatives
  • 13.3.14. Thermo Fisher Scientific, Inc.
    • 13.3.14.1. Company overview
    • 13.3.14.2. Financial performance
    • 13.3.14.3. Product benchmarking
    • 13.3.14.4. Strategic initiatives
  • 13.3.15. Wuxi Apptec
    • 13.3.15.1. Company overview
    • 13.3.15.2. Financial performance
    • 13.3.15.3. Product benchmarking
    • 13.3.15.4. Strategic initiatives
  • 13.3.16. Samsung Biologics
    • 13.3.16.1. Company overview
    • 13.3.16.2. Financial performance
    • 13.3.16.3. Product benchmarking
    • 13.3.16.4. Strategic initiatives
  • 13.3.17. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
    • 13.3.17.1. Company overview
    • 13.3.17.2. Financial performance
    • 13.3.17.3. Product benchmarking
    • 13.3.17.4. Strategic initiatives
  • 13.3.18. Lonza
    • 13.3.18.1. Company overview
    • 13.3.18.2. Financial performance
    • 13.3.18.3. Product benchmarking
    • 13.3.18.4. Strategic initiatives
  • 13.3.19. Catalent Pharma Solutions
    • 13.3.19.1. Company overview
    • 13.3.19.2. Financial performance
    • 13.3.19.3. Product benchmarking
    • 13.3.19.4. Strategic initiatives
  • 13.3.20. Jubilant Pharmova Limited
    • 13.3.20.1. Company overview
    • 13.3.20.2. Financial performance
    • 13.3.20.3. Product benchmarking
    • 13.3.20.4. Strategic initiatives